Every year on January 30th, the global health and development community comes together to acknowledge World Neglected Tropical Disease...

Novel approach for minimizing investment risks and stretching limited budgets has 375 infectious disease innovations under development...

The European Vaccine Initiative (EVI) has selected McKinsey & Company to develop a business plan, including suitable governance structure...

We recently worked with Health Awareness on the 2020 Value of Vaccines campaign. A printed publication was enclosed within every copy of...

Recently the World Malaria report reviewed 20 years of malaria response. Since 2000, 7.6 million lives have been saved globally and 1.5...

We are launching our Advent Calendar for the month of December. Get to know something about who we are and what we do, each day. Follow...

The global HIV/AIDS burden has decreased significantly in the last 10 years. New HIV infections have been reduced by 23% since 2010...

The RICH Symposium on “Research Infrastructures as Engines for Maximising Impact of Horizon Europe” brought together around 180...

On his latest interview, European Vaccine Initiative's executive director, Ole Olesen, shares his experience during the first nine months...

Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not...

Rapid progress towards the development of potent vaccines can only happen through concerted and coordinated efforts around Europe

Funding from European Commission will provide further support for design and establishment of stable vaccine infrastructure

Open call for TRANSVAC Vaccine Development Services and Training. Apply Now!

TRANSAVC2 launches call to access training in vaccinology and clinical vaccine development and manufacturing.

EVI remains firmly committed to supporting malaria vaccine development

Researchers developing vaccine candidates against COVID19 can benefit from TRANSVAC2 services

EVI’s Board of Directors is pleased to announce the appointment of Ole Olesen, PhD, as the organisation’s new Executive Director.

EVI together with partners and sponsors from China organised a two-day vaccine collaboration workshop from 9-10 November in Chengdu, China.

Funding from EDCTP will allow testing of a novel whole-cell inactivated oral vaccine in clinical trials in Europe and Africa The European...

The ZIKAVAX consortium announced today the initiation of a Phase 1 clinical trial of a second-generation Zika vaccine. The vaccine...

Horizon2020 award to consortium will support the testing of an innovative live attenuated vaccine in phase I clinical trials in Europe...

We invite you to read more about how we advanced the development of urgently needed vaccines and other activities we undertook in 2018.

Join the SENET project´s Group Meetings and have a say within the health research and innovation landscape between the EU and China!

“Zero Malaria Starts with Me”